Latest From Scrip Team
Coronavirus Update: WHO Suspends Hydroxychloroquine Trial, Novavax Launches Phase I/II Vaccine Study
Mounting evidence that President Trump's 'game changer' does more harm than good for COVID-19 patients. Novovax and Medicago among the latest vaccine developers to report progress.
Inovio vaccine data published, US government invests to protect, generic remdesivir launched in Bangladesh.
Gilead is preparing to unveil its long-term commercial plan for the antiviral therapy, including its expectations on prices and profits.
US government will fund 'at risk' manufacturing of lead vaccine candidates, with Trump promising US will get priority. But skeptics say year-end timeline is unrealistic.
Coronavirus Update: EU Regulator Skeptical On Vaccine This Year, Takeda Prepares Hyperimmune Alliance
EMA leader doesn't share Oxford's optimism, Takeda-led alliance forges ahead with plasma-derived therapy plans, Indian pharma firm Cadila gets into testing kits.
Moderna gets green light to proceed to Phase II trial of mRNA vaccine, with its eagerly-awaited Phase I results expected shortly.